US needs to overhaul its medical supply chains, bipartisan lawmakers agree

He emphasized that the U.S. can not be reliant on countries that have actually traditionally served as foes..

More posts on supply chain:6 million medical gloves taken from Florida supplier3M making more N95 masks than ever as COVID-19 surges, CEO saysStamford Health CEO, VP on how the system prevented supply shortages, how its getting ready for another COVID-19 wave.

Rep. Buddy Carter, R-Ga., informed The Hill that the pandemic has triggered the U.S. to recognize its dependence on other nations for pharmaceutical needs which “having recognized it implies we need to find a solution for it.”.

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by click on this link.

The U.S. needs to upgrade its medical supply chains and minimize its reliance on foreign nations, bipartisan legislators informed The Hill during a virtual event..

” My experience in the Pentagon and in the nationwide security world, it type of blew my mind that while we still truly like making things in America– [like] our military devices, our body armor, our meals-ready-to-eat, we didnt have the exact same buy American requirements on other things, like medical supplies and pharmaceuticals,” Ms. Slotkin informed The Hill.

Mr. Carter introduced the Manufacturing API, Drugs and Excipients in America Act to keep supply chains in the U.S..

Rep. Elissa Slotkin, D-Mich., said the U.S. requires a “soup-to-nuts” view of the particular supply chains that have nationwide security significance. Ms. Slotkin is the lead sponsor of the Made in America Medical Supply Chain Initiative, a plan of 6 costs aimed at decreasing dependence on foreign medical supply chains, The Hill reported.” We had risks from China that said, Yeah, were glad to send you this medication. Thats not the kind of situation we need to be in.

Maia Anderson –
Wednesday, October 28th, 2020
Print|Email.

” We had dangers from China that stated, Yeah, were glad to send you this medication. Were going to use what we have to use initially, and if theres anything left over, then well send it to you. Thats not the type of circumstance we require to be in. Thats not in the best interest of the healthcare of our citizens, nor is it in the best interest of our national defense,” Mr. Carter told The Hill..
Check out the complete article here.

Rep. Elissa Slotkin, D-Mich., said the U.S. needs a “soup-to-nuts” view of the specific supply chains that have nationwide security importance. Ms. Slotkin is the lead sponsor of the Made in America Medical Supply Chain Initiative, a package of six expenses focused on decreasing dependence on foreign medical supply chains, The Hill reported. The package consists of a $500 million pilot program to incentivize domestic makers to produce crucial supplies such as individual protective devices..